Iconovo (ICO) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.035x

Based on the latest financial reports, Iconovo (ICO) has a cash flow conversion efficiency ratio of -0.035x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-5.48 Million ≈ $-589.95K USD) by net assets (Skr157.77 Million ≈ $16.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Iconovo liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Iconovo - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Iconovo's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Iconovo Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Iconovo ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Boa Concept SA
PA:ALBOA
0.010x
Astute Metals NL
AU:ASE
-0.011x
Phio Pharmaceuticals Corp
NASDAQ:PHIO
-0.243x
Lunai Bioworks Inc.
NASDAQ:LNAI
0.079x
SSH Group Ltd
AU:SSH
0.196x
HF Company SA
PA:ALHF
0.038x
Kalo Gold Corp
NASDAQ:KLGDD
-2.311x
Hindcon Chemicals Limited
NSE:HINDCON
0.047x

Annual Cash Flow Conversion Efficiency for Iconovo (2016–2025)

The table below shows the annual cash flow conversion efficiency of Iconovo from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see ICO stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr117.92 Million
≈ $12.69 Million
Skr-31.87 Million
≈ $-3.43 Million
-0.270x -42.31%
2024-12-31 Skr129.21 Million
≈ $13.91 Million
Skr-24.54 Million
≈ $-2.64 Million
-0.190x +44.15%
2023-12-31 Skr113.53 Million
≈ $12.22 Million
Skr-38.60 Million
≈ $-4.15 Million
-0.340x +30.53%
2022-12-31 Skr89.29 Million
≈ $9.61 Million
Skr-43.70 Million
≈ $-4.70 Million
-0.489x -509.02%
2021-12-31 Skr137.03 Million
≈ $14.75 Million
Skr-11.01 Million
≈ $-1.19 Million
-0.080x +53.31%
2020-12-31 Skr92.73 Million
≈ $9.98 Million
Skr-15.96 Million
≈ $-1.72 Million
-0.172x -54.97%
2019-12-31 Skr108.79 Million
≈ $11.71 Million
Skr-12.08 Million
≈ $-1.30 Million
-0.111x -599.12%
2018-12-31 Skr63.99 Million
≈ $6.89 Million
Skr-1.02 Million
≈ $-109.38K
-0.016x +86.88%
2017-12-31 Skr31.52 Million
≈ $3.39 Million
Skr-3.82 Million
≈ $-410.77K
-0.121x -117.56%
2016-12-31 Skr8.73 Million
≈ $939.49K
Skr6.02 Million
≈ $647.74K
0.689x --

About Iconovo

ST:ICO Sweden Medical Devices
Market Cap
$11.95 Million
Skr111.08 Million SEK
Market Cap Rank
#26601 Global
#576 in Sweden
Share Price
Skr1.16
Change (1 day)
-0.43%
52-Week Range
Skr1.04 - Skr2.63
All Time High
Skr95.00
About

Iconovo AB (publ) develops inhaled medicinal products in Sweden. The company offers ICOres, a multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler; and ICOone nasal single-dose dry powder inhaler for nasal use. It serves generic companies. The company has a collaboration agreeme… Read more